Found: 24
Select item for more details and to access through your institution.
Dantrolene reduces CaMKIIδC-mediated atrial arrhythmias.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sex-dependent alterations of Ca2+ cycling in human cardiac hypertrophy and heart failure.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Structural Analysis of Mitochondrial Dynamics—From Cardiomyocytes to Osteoblasts: A Critical Review.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 9, p. 4571, doi. 10.3390/ijms23094571
- By:
- Publication type:
- Article
Detrimental proarrhythmogenic interaction of Ca<sup>2+</sup>/calmodulin-dependent protein kinase II and Na<sub>V</sub>1.8 in heart failure.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26690-1
- By:
- Publication type:
- Article
Empagliflozin enhances human and murine cardiomyocyte glucose uptake by increased expression of GLUT1.
- Published in:
- Diabetologia, 2019, v. 62, n. 4, p. 726, doi. 10.1007/s00125-019-4819-z
- By:
- Publication type:
- Article
Atrial fibrillation and heart failure: novel insights into the chicken and egg dilemma.
- Published in:
- European Heart Journal, 2022, v. 43, n. 36, p. 3376, doi. 10.1093/eurheartj/ehac257
- By:
- Publication type:
- Article
Differential regulation of sodium channels as a novel proarrhythmic mechanism in the human failing heart.
- Published in:
- Cardiovascular Research, 2018, v. 114, n. 13, p. 1728, doi. 10.1093/cvr/cvy152
- By:
- Publication type:
- Article
Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation.
- Published in:
- Cardiovascular Research, 2021, v. 117, n. 2, p. 495, doi. 10.1093/cvr/cvaa123
- By:
- Publication type:
- Article
A mechanistic rationale for the investigation of sodium–glucose co‐transporter 2 inhibitors in heart failure with preserved ejection fraction. Letter regarding the article 'Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR‐Preserved trial'
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 5, p. 841, doi. 10.1002/ejhf.2091
- By:
- Publication type:
- Article
Empagliflozin directly improves diastolic function in human heart failure.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Activation of protein phosphatase 1 by a selective phosphatase disrupting peptide reduces sarcoplasmic reticulum Ca<sup>2+</sup> leak in human heart failure.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Simulation of cardiac arrhythmias in human induced pluripotent stem cell-derived cardiomyocytes.
- Published in:
- PLoS ONE, 2024, v. 19, n. 9, p. 1, doi. 10.1371/journal.pone.0310463
- By:
- Publication type:
- Article
Empagliflozin inhibits Na<sup>+</sup>/H<sup>+</sup> exchanger activity in human atrial cardiomyocytes.
- Published in:
- ESC Heart Failure, 2020, v. 7, n. 6, p. 4429, doi. 10.1002/ehf2.13024
- By:
- Publication type:
- Article
The oral Ca/calmodulin‐dependent kinase II inhibitor RA608 improves contractile function and prevents arrhythmias in heart failure.
- Published in:
- ESC Heart Failure, 2020, v. 7, n. 5, p. 2871, doi. 10.1002/ehf2.12895
- By:
- Publication type:
- Article
The functional consequences of sodium channel Na<sub>V</sub>1.8 in human left ventricular hypertrophy.
- Published in:
- ESC Heart Failure, 2019, v. 6, n. 1, p. 154, doi. 10.1002/ehf2.12378
- By:
- Publication type:
- Article
Empagliflozin reduces Ca/calmodulin‐dependent kinase II activity in isolated ventricular cardiomyocytes.
- Published in:
- ESC Heart Failure, 2018, v. 5, n. 4, p. 642, doi. 10.1002/ehf2.12336
- By:
- Publication type:
- Article
Enhanced Heart Failure in Redox-Dead Cys17Ser PKARIα Knock-In Mice.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Electrophysiological and calcium-handling development during long-term culture of human-induced pluripotent stem cell-derived cardiomyocytes.
- Published in:
- Basic Research in Cardiology, 2023, v. 118, n. 1, p. 1, doi. 10.1007/s00395-022-00973-0
- By:
- Publication type:
- Article
Tachycardiomyopathy entails a dysfunctional pattern of interrelated mitochondrial functions.
- Published in:
- Basic Research in Cardiology, 2022, v. 117, n. 1, p. 1, doi. 10.1007/s00395-022-00949-0
- By:
- Publication type:
- Article
Doxorubicin induces cardiotoxicity in a pluripotent stem cell model of aggressive B cell lymphoma cancer patients.
- Published in:
- Basic Research in Cardiology, 2022, v. 117, n. 1, p. 1, doi. 10.1007/s00395-022-00918-7
- By:
- Publication type:
- Article
Inhibition of Na<sub>V</sub>1.8 prevents atrial arrhythmogenesis in human and mice.
- Published in:
- Basic Research in Cardiology, 2020, v. 115, n. 2, p. 1, doi. 10.1007/s00395-020-0780-8
- By:
- Publication type:
- Article
Long-term effects of empagliflozin on excitation-contraction-coupling in human induced pluripotent stem cell cardiomyocytes.
- Published in:
- Journal of Molecular Medicine, 2020, v. 98, n. 12, p. 1689, doi. 10.1007/s00109-020-01989-6
- By:
- Publication type:
- Article
Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction.
- Published in:
- Frontiers in Physiology, 2021, v. 12, p. 1, doi. 10.3389/fphys.2021.752370
- By:
- Publication type:
- Article
Comparative Analysis of Mitochondria Surrounding the Intercalated Discs in Heart Diseases—An Ultrastructural Pilot Study.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 14, p. 7644, doi. 10.3390/ijms25147644
- By:
- Publication type:
- Article